GurmHSBhattDLLincoffAM, et al.Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart. 2003;89:1200–4.
2.
KounisNGMazarakisA. Ratios, ratios and ratios of white blood count for evaluation of inflammatory conditions. Eur Rev Med Pharmacol Sci. 2015;19:4679-80.
3.
KurtulAOrnekE. Platelet to lymphocyte ratio in cardiovascular diseases: a systematic review. Angiology. 2019;70:802-18.
4.
OylumluMYildizAOylumluM, et al.Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome. Anatol J Cardiol. 2015;15:277–83.
5.
TemizAGaziEGungorO, et al.Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit. 2014;20:660–5.
6.
ZhangEGaoMGaoJ, et al.Inflammatory and hematological indices as simple, practical severity predictors of microdysfunction following coronary intervention: a systematic review and meta-analysis. Angiology. 2020;71:349-59.
7.
BruunsgaardHLadelundSPedersenANSchrollMJørgensenTPedersenBK. Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol. 2003;132:24–31.
8.
GordonCJRowseyPJBishopBLWardWOMacphailRC. Serum biomarkers of aging in the Brown Norway rat. Exp Gerontol. 2011;46:953–7.
9.
ChungHYSungBJungKJZouYYuBP. The molecular inflammatory process in aging. Antioxid Redox Signal. 2006;8:572–81.
10.
JungKJLeeEKYuBPChungHY. Significance of protein tyrosine kinase/protein tyrosine phosphatase balance in the regulation of NF-kappaB signaling in the inflammatory process and aging. Free Radic Biol Med. 2009;47:983–991.
11.
ChungHYKimDHLeeEK, et al.Redefining chronic inflammation in aging and age-related diseases: proposal of the seno inflammation concept. Aging Dis. 2019;10:367-82.
12.
KounisNGGiannopoulosSTsigkasGGGoudevenosJ. Eosinophilic responses to stent implantation and the risk of Kounis hypersensitivity associated coronary syndrome. Int J Cardiol. 2012;156:125-32.
13.
KounisNGKoniariIRoumeliotisA, et al.Thrombotic responses to coronary stents, bioresorbable scaffolds and the Kounis hypersensitivity-associated acute thrombotic syndrome. J Thorac Dis. 2017;9:1155-64. [published correction appears in J Thorac Dis. 2019;11: E17]
14.
MehtaSRYusufS. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. J Am Coll Cardiol. 2003;41:79S–88S.
15.
JagroopIAClatworthyILewinJMikhailidisDP. Shape change in human platelets: measurement with a channelyzer and visualisation by electron microscopy. Platelets. 2000;11:28-32.
16.
ShahBHLashariIRanaSSaeedORasheedHArshad SaeedS. Synergistic interaction of adrenaline and histamine in human platelet aggregation is mediated through activation of phospholipase, map kinase and cyclo-oxygenase pathways. Pharmacol Res. 2000;42:479–83.
17.
LoskutoffDJSamadF. The adipocyte and haemostatic balance in obesity: studies of PAI-1. Arterioscler Thromb Vasc Biol. 1998;18:1–6.
18.
TerposENtanasis-StathopoulosIElalamyI, et al.Hematological findings and complications of COVID-19. Am J Hematol. 2020; 95:834-47.
19.
LiLMaYGengXB, et al.Platelet-to-lymphocyte ratio relates to poor prognosis in elderly patients with acute myocardial infarction[published online ahead of print]. Aging Clin Exp Res. 2020: 10.1007/s40520–020-01555–7.
20.
KounisNGHahalisG. White blood cell counts in predicting cardiovascular events: the racial ratios. Coron Artery Dis. 2015;26:369-71.
